Quorum sensing-mediated regulation of virulence and biofilm formation in gram-negative pathogens: Mechanisms, inhibitory strategies, and therapeutic perspectives
Journal of Advances in Microbiology Research · 01.01.2026 · 7 (1) · 44-49
DOI: 10.22271/micro.2026.v7.i1a.349 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Advances in Microbiology Research, online erschienen am 01.01.2026. Verfasst von Yilmaz Karahan.
Abstract (Originalsprache)
Why do bacteria behave so differently at high population densities than they do as isolated cells? The answer lies in a sophisticated chemical communication system known as quorum sensing (QS)-a density-dependent regulatory mechanism through which bacteria monitor their own population and co-ordinate collective behaviours once a critical cell number is reached. Among the consequences of QS activation, two stand out for their clinical relevance: the expression of virulence factor genes and the formation of antibiotic-tolerant biofilms. This review examines the molecular architecture of QS systems in Gram-negative pathogens, with particular focus on Pseudomonas aeruginosa, Acinetobacter baumannii, and Burkholderia cepacia-organisms responsible for a disproportionate share of nosocomial infections in immunocompromised and critically ill patients. The canonical acyl-homoserine lactone (AHL)-based QS circuit, comprising the LuxI-type synthase and LuxR-type receptor, is described in detail alongside the Pseudomonas Quinolone Signal (PQS) system unique to P. aeruginosa. The review then surveys the breadth of QS inhibitor (QSI) strategies currently under investigation, classifying them as enzyme-based (lactonases, acylases), receptor-competitive (LuxR antagonists), and natural compound-derived (halogenated furanones, ajoene, curcumin, quercetin, and epigallocatechin gallate). Evidence from in vitro biofilm models and animal infection models is assessed, with attention to both efficacy and the risk of resistance selection. The important distinction between QSI compounds, which reduce virulence without killing bacteria, and conventional bactericidal agents is discussed in terms of selective pressure and resistance evolution. Gaps in the current evidence base-particularly the lack of clinical trial data and challenges in in vivo delivery of QSI compounds-are identified alongside emerging approaches such as nanoparticle-encapsulated QSI formulations and combination QSI-antibiotic regimens. The review concludes that QS inhibition represents a scientifically well-grounded anti-virulence strategy with genuine therapeutic promise, though translation to clinical application requires resolution of pharmacokinetic and regulatory challenges.
Zitieren
APA
Karahan, Y. (2026). Quorum sensing-mediated regulation of virulence and biofilm formation in gram-negative pathogens: Mechanisms, inhibitory strategies, and therapeutic perspectives. Journal of Advances in Microbiology Research, 7(1), 44-49. https://doi.org/10.22271/micro.2026.v7.i1a.349
Vancouver
Karahan Y. Quorum sensing-mediated regulation of virulence and biofilm formation in gram-negative pathogens: Mechanisms, inhibitory strategies, and therapeutic perspectives. Journal of Advances in Microbiology Research. 2026;7(1):44-49. doi:10.22271/micro.2026.v7.i1a.349
BibTeX
@article{Karahan2026,
author = {Karahan, Yilmaz},
title = {Quorum sensing-mediated regulation of virulence and biofilm formation in gram-negative pathogens: Mechanisms, inhibitory strategies, and therapeutic perspectives},
journal = {Journal of Advances in Microbiology Research},
year = {2026},
volume = {7},
number = {1},
pages = {44--49},
doi = {10.22271/micro.2026.v7.i1a.349}
}
EUVIMED